Published by Benjamin Chiou on 2nd January 2024
(Sharecast News) - Shares in AIM-listed biotech group Sareum jumped by a fifth on Tuesday after its co-development partner for cancer treatment SRA737 signed a commercialisation licence agreement with a US biopharma company.
URL: http://www.digitallook.com/dl/news/story/33999160/...